omeprazole has been researched along with misoprostol in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (8.89) | 18.7374 |
1990's | 38 (42.22) | 18.2507 |
2000's | 37 (41.11) | 29.6817 |
2010's | 6 (6.67) | 24.3611 |
2020's | 1 (1.11) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Dajani, EZ; Ives, MM; Larsen, KR | 1 |
Agrawal, NM | 2 |
Fidanza, F; Pace, V; Zechini, F | 1 |
Arakawa, T; Fukuda, T; Higuchi, K; Kobayashi, K; Nakamura, H | 1 |
Chen, BW; Cho, CH; Hui, WM; Lam, SK; Luk, CT | 1 |
Earnest, DL | 1 |
Fields, JZ; Haydek, JM; Keshavarzian, A; Stinneford, JG; Zepeda, DO | 1 |
Amouzadeh, HR; MacAllister, CC; Sangiah, S | 1 |
Mahachai, V; Thomson, AB | 1 |
Dammann, HG; Müller, P; Simon, B | 2 |
Gugler, R | 2 |
Dammann, HG; Kommerell, B; Müller, P; Simon, B | 1 |
McColl, KE | 1 |
Blandizzi, C; Carignani, D; Del Tacca, M; Gherardi, G; Marveggio, C; Natale, G | 1 |
Piper, DW | 1 |
Dowling, PM | 1 |
Hirschowitz, BI | 1 |
Shi, GY | 1 |
Abbasciano, V; Nielsen, I; Sartori, S; Tassinari, D; Trevisani, L | 1 |
Bertschinger, P; Fried, M | 1 |
Ardizzone, S; Bianchi Porro, G | 1 |
Alvisi, V; Bajocchi, G; Caselli, M; La Corte, R; Ruina, M; Trotta, F | 1 |
Branicki, FJ; Chen, BW; Cho, CH; Ho, J; Hui, WM; Lam, SK | 1 |
Barkun, A; Hawkey, CJ; Karrasch, JA; Swannell, AJ; Szczepañski, L; Walker, DG; Yeomans, ND | 1 |
Talley, NJ | 1 |
Lanza, FL | 1 |
Jönsson, B; Wahlqvist, P | 1 |
Chan, FK; Sung, JJ | 1 |
Guslandi, M | 1 |
Evans, MF; Gautam, M; Por, CP | 1 |
Cammarota, G; Cianci, R; Cuoco, L; Fedeli, G; Gasbarrini, G; Papa, A; Tursi, A | 1 |
Langman, MJ | 1 |
Bell, AD | 1 |
Isenberg, J; Scheiman, J | 1 |
Fendrick, AM; Scheiman, JM | 1 |
Hawkey, CJ | 1 |
Raskin, JB | 1 |
Alexander, JH; Forman, MD; Godwin, KS; House, JK; Knebl, JA; Pertusi, RM; Rubin, BR | 1 |
Beglinger, C; Lehmann, FS | 1 |
Knol, A | 1 |
Salentijn, GJ | 1 |
Soto Alvarez, J | 1 |
Graham, DY | 2 |
Lanas, AI | 1 |
Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I | 1 |
Blandizzi, C; Del Tacca, M; Gherardi, G; Lazzeri, G; Lenzi, P; Natale, G; Pellegrini, A | 1 |
Karateev, AE; Murav'ev, IuV | 1 |
McCarthy, DM | 1 |
Naesdal, J; Wilson, I | 1 |
Akcay, MF; Banoglu, ZN; Büyükokuroglu, ME; Demirezer, LO; Gepdiremen, A; Göçer, F; Süleyman, H | 1 |
Agrawal, NM; Campbell, DR; Collis, C; Graham, DY; Haber, MM; Huang, B; Lukasik, NL | 1 |
Hawkey, C; Långström, G; Naesdal, J; Walan, A; Wiklund, I; Wilson, I; Yeomans, N | 1 |
Nakamura, T | 1 |
Matsuoka, T; Miyazawa, K; Mizokami, Y; Nakamura, H; Narushima, K; Otsubo, T; Shiraishi, T | 1 |
Hawkey, CJ; Långström, G; Naesdal, J; Peacock, RA; Swannell, AJ; Wilson, I; Yeomans, ND | 1 |
Hawkey, CJ; Långström, G; Naesdal, J; Swannell, AJ; Wilson, I; Yeomans, ND | 1 |
Tsuji, S | 1 |
Goto, M; Imaeda, H; Ishii, H | 1 |
Fernández-Fernández, FJ | 1 |
Gitlin, N; Weaver, AL | 1 |
Bae, SC; Yun, HR | 1 |
Bernsand, M; Bjorkqvist, M; Ericsson, P; Hakanson, R; Norlen, P; Zhao, CM | 1 |
Oviedo, JA; Wolfe, MM | 1 |
Dietrich, K; Fischer, R; González-Carro, P; Lühmann, R; Straszak, A; Stupnicki, T; Terjung, A; Thomas, KB | 1 |
Kotaira, J | 1 |
Amer, F; Christopoulos, NG; Goldstein, JL; Huang, B | 1 |
Gautam, P; Poonam, D; Vinay, CS | 1 |
Arisawa, T; Fujita, H; Harata, M; Hasegawa, S; Kamiya, Y; Mizuno, T; Nagasaka, M; Nakamura, M; Nakano, H; Ohta, Y; Shibata, T; Tahara, T | 1 |
Bayan, K; Canoruç, F; Daniş, R; Dursun, M; Ertem, M; Kilinç, N; Tüzün, Y; Yilmaz, S | 1 |
Loshchakova, OIu; Vakhrushev, IaM | 1 |
Bandivdeker, AH; Bandyopadhyay, SK; Banerjee, D; Chattopadhyay, S; Maity, B | 1 |
Hashiguchi, M; Mochizuki, M; Uchikura, T; Yamauchi, N | 1 |
Bobb, A; Bulsiewicz, W; Christensen, K; Coté, GA; Howden, CW; Norvell, JP; Postelnick, M; Rice, JP | 1 |
Ehara, A; Fujimori, S; Gudis, K; Kobayashi, T; Mitsui, K; Sakamoto, C; Seo, T; Tanaka, S; Tatsuguchi, A; Yonezawa, M | 1 |
Apikoglu-Rabus, S; Cevikbas, U; Izzettin, FV; Okuyan, B; Sancar, M | 1 |
Aleman, M; Higgins, JK; Nieto, JE | 1 |
Adhikary, B; Bandyopadhyay, SK; Chattopadhyay, S; Yadav, SK | 1 |
Amagase, K; Satoh, H; Takeuchi, K | 1 |
Bowen, IM; Habershon-Butcher, JL; Hallowell, GD; Nicholls, V; Varley, G | 1 |
Bailey, J; Bowen, M; Hallowell, GH; Pratt, SL; Redpath, A; Shipman, E | 1 |
22 review(s) available for omeprazole and misoprostol
Article | Year |
---|---|
Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Topics: Alprostadil; Antacids; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Enprostil; Famotidine; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Prostaglandins E, Synthetic; Ranitidine; Sucralfate; Thiazoles | 1987 |
Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Enprostil; Gastric Juice; Gastrins; Humans; Misoprostol; Omeprazole; Prostaglandins E, Synthetic; Stomach Ulcer | 1988 |
A comparative overview of the adverse effects of antiulcer drugs.
Topics: Antacids; Anti-Ulcer Agents; Carcinoid Tumor; Cimetidine; Humans; Misoprostol; Omeprazole; Ranitidine; Sucralfate | 1995 |
Therapy of gastrointestinal ulcers.
Topics: Animals; Antacids; Anti-Ulcer Agents; Histamine H2 Antagonists; Misoprostol; Omeprazole; Peptic Ulcer; Sucralfate | 1995 |
Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Humans; Misoprostol; Omeprazole; Prevalence; Ranitidine; Risk Factors; Stomach Ulcer; Sucralfate | 1995 |
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Digestive System; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Intestinal Perforation; Intestine, Large; Intestine, Small; Misoprostol; Omeprazole; Osteoarthritis; Peptic Ulcer; Sucralfate | 1994 |
[Prevention and therapy of NSAID-induced ulcers: fact versus myth].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Comorbidity; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Risk Factors | 1996 |
Prevention of NSAID-gastropathy.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Risk Factors; Sialoglycoproteins; Stomach Ulcer | 1996 |
Therapy of NSAIDs-induced gastropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Stomach Ulcer | 1996 |
Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Dyspepsia; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Wound Healing | 1998 |
Prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions: a commentary on the new data.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Treatment Outcome | 1998 |
Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cost-Benefit Analysis; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Sweden | 1998 |
Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Gastric Mucosa; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 1998 |
Gastrointestinal effects of nonsteroidal anti-inflammatory therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Digestive System; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Isoenzymes; Membrane Proteins; Misoprostol; Omeprazole; Prevalence; Prostaglandin-Endoperoxide Synthases; Stomach Ulcer | 1999 |
[Present position in the prevention and therapy of NSAID-induced ulcers].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer; Gastric Mucosa; Humans; Intestinal Mucosa; Misoprostol; Omeprazole; Risk Factors; Stomach Ulcer | 1999 |
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2001 |
Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Diseases; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Risk Factors; Sucralfate | 2001 |
Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Histamine H2 Antagonists; Humans; Isoenzymes; Lansoprazole; Membrane Proteins; Misoprostol; Omeprazole; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors | 2001 |
[The outline of medical treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Prevention and treatment of gastro-duodenal ulcers in elderly--from theory-based toward evidence-based].
Topics: Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Evidence-Based Medicine; Humans; Misoprostol; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer | 2002 |
[Treatment of peptic ulcer related to rheumatic diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Histamine H2 Antagonists; Humans; Lupus Erythematosus, Systemic; Misoprostol; Omeprazole; Peptic Ulcer; Polyarteritis Nodosa; Proton Pump Inhibitors; Rheumatic Diseases | 2002 |
Gastroprotection by coxibs: what do the Celecoxib Long-Term Arthritis Safety Study and the Vioxx Gastrointestinal Outcomes Research Trial tell us?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Enzyme Inhibitors; Gastrointestinal Hemorrhage; Humans; Lactones; Misoprostol; Omeprazole; Osteoarthritis; Proton Pump Inhibitors; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones | 2003 |
16 trial(s) available for omeprazole and misoprostol
Article | Year |
---|---|
H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dinoprostone; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Peptic Ulcer; Wound Healing | 1991 |
[Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Topics: Adult; Alprostadil; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Gastric Mucosa; Gastroscopy; Humans; Misoprostol; Omeprazole; Prostaglandins E; Prostaglandins, Synthetic; Random Allocation; Ranitidine; Rioprostil; Stomach Ulcer | 1986 |
[Drug therapy of peptic ulcer. What is coming up?].
Topics: Alprostadil; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Enprostil; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Prostaglandins E, Synthetic; Ranitidine | 1987 |
[Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study].
Topics: Adult; Alprostadil; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Gastroscopy; Humans; Indomethacin; Misoprostol; Omeprazole; Prostaglandins E; Ranitidine; Rioprostil; Stomach Ulcer | 1987 |
Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study.
Topics: Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gastric Acid; Gastric Mucosa; Humans; Male; Methotrexate; Middle Aged; Misoprostol; Omeprazole; Peptic Ulcer; Pilot Projects | 1996 |
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Dyspepsia; Female; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Prognosis; Proton Pump Inhibitors; Recurrence; Remission Induction; Stomach Ulcer | 1998 |
Omeprazole in the treatment of ulcers induced by NSAIDs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Randomized Controlled Trials as Topic; Recurrence; Stomach Ulcer; Wound Healing | 1998 |
Healing and prevention of NSAID-associated ulcer disease: is seeing believing?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Endoscopy; Humans; Misoprostol; Omeprazole; Ranitidine; Secondary Prevention; Ulcer; Wound Healing | 1998 |
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer | 2002 |
Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cohort Studies; Female; Humans; Long-Term Care; Male; Middle Aged; Misoprostol; Norway; Omeprazole; Probability; Quality of Life; Reference Values; Risk Assessment; Severity of Illness Index; Sickness Impact Profile; Stomach Ulcer; Stress, Psychological | 2001 |
Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pantoprazole; Rheumatic Diseases; Risk Factors; Sulfoxides | 2003 |
[Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Misoprostol; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2004 |
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Humans; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Ulcer; Treatment Outcome | 2004 |
Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Comorbidity; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Recurrence | 2007 |
Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Diclofenac; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Misoprostol; Omeprazole; Prostaglandins E, Synthetic; Proton Pump Inhibitors; Single-Blind Method; Young Adult | 2009 |
Misoprostol is superior to combined omeprazole-sucralfate for the treatment of equine gastric glandular disease.
Topics: Animals; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Horse Diseases; Horses; Male; Misoprostol; Odds Ratio; Omeprazole; Stomach Diseases; Sucralfate | 2019 |
52 other study(ies) available for omeprazole and misoprostol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antiulcer drugs and gastric mucosal integrity. Effects of misoprostol, 16,16-dimethyl PGE2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Ulcer Agents; Cell Membrane Permeability; Cimetidine; Dogs; Female; Gastric Mucosa; Male; Misoprostol; Omeprazole; Oxygen Consumption; Potassium Channels; Regional Blood Flow; Sodium Channels | 1992 |
Making sense of NSAID gastropathy and considering the therapeutic options.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Stomach Diseases; Sucralfate | 1992 |
[Omeprazole and misoprostol in acute gastroduodenal pathology. Physiopathological and therapeutic considerations in a surgical study].
Topics: Acute Disease; Humans; Misoprostol; Omeprazole; Peptic Ulcer | 1992 |
Drugs for treatment of peptic ulcers.
Topics: Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Sucralfate | 1991 |
Role of gastric mucosal blood flow in cytoprotection.
Topics: Alprostadil; Animals; Anti-Ulcer Agents; Cimetidine; Ethanol; Gastric Mucosa; Lasers; Male; Misoprostol; Omeprazole; Rats; Rats, Inbred Strains; Regional Blood Flow; Stomach Ulcer; Sucralfate | 1991 |
Controlling gastric pH: the impact of newer agents on the critically ill patient.
Topics: Alprostadil; Anti-Ulcer Agents; Critical Care; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Misoprostol; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Proglumide; Risk Factors; Somatostatin; Stomach Ulcer; Stress, Physiological | 1990 |
Gastroduodenal ulcers in rats induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): requirement for gastric acid secretion and the role of prostaglandins.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alprostadil; Animals; Atropine; Duodenal Ulcer; Female; Gastric Acid; Injections, Subcutaneous; Misoprostol; Omeprazole; Prostaglandins; Rats; Rats, Inbred F344; Stomach Ulcer; Time Factors | 1990 |
Effects of misoprostol and omeprazole on basal gastric pH and free acid content in horses.
Topics: Administration, Oral; Alprostadil; Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Horses; Hydrogen-Ion Concentration; Injections, Intravenous; Misoprostol; Omeprazole; Random Allocation | 1989 |
[New developments in ulcer therapy: famotidine, omeprazole misoprostol].
Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles | 1986 |
[Peptic ulcer. New H2 blockers, prostaglandins, benzimidazoles].
Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles | 1987 |
Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats.
Topics: Animals; Ethanol; Gastric Acid; Gastric Mucosa; Gastritis; Hydrochloric Acid; Male; Misoprostol; Mucus; Necrosis; Omeprazole; Ranitidine; Rats; Rats, Wistar | 1995 |
Drugs for treatment of peptic ulcers.
Topics: Antacids; Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Sucralfate | 1994 |
[Nonsteroidal antiinflammatory drugs and duodenal ulceration].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Humans; Misoprostol; Omeprazole; Stomach Ulcer | 1993 |
Can misoprostol and omeprazole reduce nicotine and ethanol induced gastric mucosal injury? A quantitative macroscopic and microscopic analysis in rats.
Topics: Animals; Anti-Ulcer Agents; Ethanol; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gastric Mucosa; Male; Misoprostol; Nicotine; Omeprazole; Rats; Rats, Sprague-Dawley | 1997 |
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Severity of Illness Index | 1998 |
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Recurrence | 1998 |
Omeprazole or misoprostol. Which works best for NSAID-induced ulcers?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Female; Humans; Male; Misoprostol; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic | 1998 |
Pre-treatment with misoprostol increases the efficacy of omeprazole plus amoxycillin to cure Helicobacter pylori infection. A pilot study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Penicillins; Pilot Projects | 1998 |
Misoprostol vs omeprazole for ulcers associated with NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Therapeutic Equivalency; Treatment Outcome | 1998 |
Omeprazole and bleeding peptic ulcer, or "how case-control studies can tell you what you suspected all along".
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Case-Control Studies; Confounding Factors, Epidemiologic; Gastrointestinal Hemorrhage; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Recurrence; Research Design | 1999 |
Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners.
Topics: Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Costs and Cost Analysis; Data Collection; Drug Prescriptions; Female; Gastrointestinal Diseases; Histamine H2 Antagonists; Humans; Male; Misoprostol; Omeprazole; Practice Patterns, Physicians'; Protective Agents; Sucralfate; Surveys and Questionnaires; United States | 1999 |
[Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Misoprostol; Omeprazole; Stomach Diseases | 1999 |
[Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Misoprostol; Omeprazole; Stomach Diseases | 1999 |
[Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Decision Trees; Diclofenac; Gastrointestinal Diseases; Humans; Misoprostol; Omeprazole; Osteoarthritis; Ranitidine | 2000 |
Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine | 2001 |
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides | 2001 |
Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Ethanol; Gastric Mucosa; Indomethacin; Male; Misoprostol; Omeprazole; Ranitidine; Rats; Rats, Wistar; Shock, Hemorrhagic; Stomach Diseases | 2001 |
[Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Stomach Ulcer; Treatment Outcome | 2001 |
Antiulcerogenic effect of Hippophae rhamnoides L.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Famotidine; Fruit; Indomethacin; Male; Misoprostol; Omeprazole; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Rosales; Stomach Ulcer; Stress, Physiological | 2001 |
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Recurrence; Treatment Outcome | 2002 |
[Treatment of NSAIDs induced ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Famotidine; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2002 |
Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cohort Studies; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Multivariate Analysis; Omeprazole; Ranitidine; Recurrence; Risk Factors; Stomach Ulcer; Treatment Failure | 2002 |
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Susceptibility; Duodenal Ulcer; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Multivariate Analysis; Omeprazole; Ranitidine; Sex Factors; Stomach Ulcer; Treatment Outcome; Wound Healing | 2002 |
Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biological Availability; Humans; Misoprostol; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stomach Ulcer | 2002 |
Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Combinations; Humans; Lansoprazole; Misoprostol; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer | 2002 |
Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Gastrointestinal Diseases; Markov Chains; Misoprostol; Omeprazole; Proton Pump Inhibitors | 2005 |
Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study.
Topics: Animals; Cells, Cultured; Endothelins; Enterochromaffin-like Cells; Epinephrine; Female; Gastric Mucosa; Gastrins; Histamine; Histamine Release; Histidine Decarboxylase; Infusions, Parenteral; Male; Methylhistidines; Microdialysis; Microinjections; Misoprostol; Omeprazole; Parietal Cells, Gastric; Pyrilamine; Ranitidine; Rats; Rats, Sprague-Dawley; Somatostatin; Time Factors | 2003 |
[Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase Inhibitors; Dyspepsia; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Proton Pump Inhibitors; Risk Factors; Stomach Ulcer; Time Factors | 2004 |
Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing.
Topics: Animals; Anti-Ulcer Agents; Blotting, Western; Celecoxib; Chronic Disease; Cyclooxygenase 2; Dinoprostone; Female; Gastric Mucosa; Male; Misoprostol; Omeprazole; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sulfonamides; Wound Healing | 2005 |
Is omeprazole or misoprostol superior for improving indomethacin-induced delayed maturation of granulation tissue in rat gastric ulcers?
Topics: Analysis of Variance; Animals; Collagen; Granulation Tissue; Hydroxyproline; Immunohistochemistry; In Situ Nick-End Labeling; Indomethacin; Male; Misoprostol; Omeprazole; Rats; Rats, Wistar; Stomach Ulcer; Wound Healing | 2006 |
[Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Biomarkers; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pirenzepine; Ranitidine; Stomach Diseases; Treatment Outcome | 2007 |
Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cell Proliferation; Dose-Response Relationship, Drug; Endostatins; Epidermal Growth Factor; Gastric Mucosa; Granulation Tissue; Indomethacin; Male; Mice; Misoprostol; Neovascularization, Physiologic; Omeprazole; Regional Blood Flow; Resorcinols; Stomach Ulcer; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2008 |
[Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Costs and Cost Analysis; Drug Therapy, Combination; Drugs, Generic; Female; Humans; Japan; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer | 2008 |
Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiology; Coronary Care Units; Female; Gastroenterology; Humans; Inservice Training; Internship and Residency; Male; Medical Order Entry Systems; Medical Records Systems, Computerized; Middle Aged; Misoprostol; Omeprazole; Patient Discharge; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Risk Factors; Software; Telemetry | 2008 |
Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Hematologic Tests; Indomethacin; Male; Misoprostol; Omeprazole; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer | 2012 |
Ulcerative cystitis associated with phenylbutazone administration in two horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cystitis; Hematuria; Horse Diseases; Horses; Male; Misoprostol; Omeprazole; Phenylbutazone; Ulcer | 2011 |
Inhibition of TNF-α, and NF-κB and JNK pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Catechols; Disease Models, Animal; Indomethacin; Male; MAP Kinase Signaling System; Mice; Misoprostol; Omeprazole; Oxidative Stress; Piper betle; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2013 |
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines | 2014 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucralfate | 2023 |